These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 836112)

  • 1. Human chorionic gonadotropin (HCG) treatment of obesity.
    Shetty KR; Kalkhoff RK
    Arch Intern Med; 1977 Feb; 137(2):151-5. PubMed ID: 836112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human chorionic gonadotropin (HCG) in the treatment of obesity: a critical assessment of the Simeons method.
    Greenway FL; Bray GA
    West J Med; 1977 Dec; 127(6):461-3. PubMed ID: 595585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term human chorionic gonadotropin-induced testosterone rise does not modify leptin levels in eugonadal men.
    Panidis D; Koliakos G; Kourtis A; Rousso D; Mavromatidis G; Triantos A; Kalahanis I
    Gynecol Endocrinol; 2002 Feb; 16(1):75-81. PubMed ID: 11915586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human chorionic gonadotrophin and weight loss. A double-blind, placebo-controlled trial.
    Bosch B; Venter I; Stewart RI; Bertram SR
    S Afr Med J; 1990 Feb; 77(4):185-9. PubMed ID: 2405506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk-benefit analysis of a hCG-500 kcal reducing diet (cura romana) in females].
    Rabe T; Richter S; Kiesel L; Runnebaum B
    Geburtshilfe Frauenheilkd; 1987 May; 47(5):297-307. PubMed ID: 3609673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with human chorionic gonadotropin and risk of breast cancer.
    Bernstein L; Hanisch R; Sullivan-Halley J; Ross RK
    Cancer Epidemiol Biomarkers Prev; 1995; 4(5):437-40. PubMed ID: 7549796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chorionic gonadotropin in weight control. A double-blind crossover study.
    Young RL; Fuchs RJ; Woltjen MJ
    JAMA; 1976 Nov; 236(22):2495-7. PubMed ID: 792477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First trimester threatened miscarriage treatment with human chorionic gonadotrophins: a randomised controlled trial.
    Qureshi NS; Edi-Osagie EC; Ogbo V; Ray S; Hopkins RE
    BJOG; 2005 Nov; 112(11):1536-41. PubMed ID: 16225575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical study of the use of human chorionic gonadotrophin in weight reduction.
    Miller R; Schneiderman LJ
    J Fam Pract; 1977 Mar; 4(3):445-8. PubMed ID: 321723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term administration of orlistat reduced daytime triglyceridemia in obese women with the metabolic syndrome.
    Tzotzas T; Samara M; Constantinidis T; Tziomalos K; Krassas G
    Angiology; 2007; 58(1):26-33. PubMed ID: 17351155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gonadic and extragonadic effects in humans of 3,500 I.U. of HCG (human chorionic gonadotropin) in fractional doses].
    Veilleux H; Fortin Z
    Vie Med Can Fr; 1972 Sep; 1(9):862-71. PubMed ID: 4654984
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term maintenance of weight loss with sibutramine in a GP setting following a specialist guided very-low-calorie diet: a double-blind, placebo-controlled, parallel group study.
    Mathus-Vliegen EM;
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S31-8; discussion S39. PubMed ID: 16052193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of GnRH analogue (buserelin) or hCG (Chorulon) on Day 12 of pregnancy on ovarian function, plasma hormone concentrations, conceptus growth and placentation in ewes and ewe lambs.
    Khan TH; Beck NF; Khalid M
    Anim Reprod Sci; 2007 Dec; 102(3-4):247-57. PubMed ID: 17174489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of obesity with chorionic gonadotropins. Relations between obesity, dyslipidemia and arthero-arteriosclerosis].
    Vallini A; Fabbri F; Candi L; Davi D
    Minerva Med; 1976 Jul; 67(33):2113-32. PubMed ID: 951038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of human chorionic gonadotropin as a replacement for gonadotropin-releasing hormone in ovulation-synchronization protocols before fixed timed artificial insemination in beef cattle.
    Burns MG; Buttrey BS; Dobbins CA; Martel CA; Olson KC; Lamb GC; Stevenson JS
    J Anim Sci; 2008 Oct; 86(10):2539-48. PubMed ID: 18539821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where can I find information on the use of human chorionic gonadotrophin (HCG) for weight loss?
    Cunningham E
    J Am Diet Assoc; 2010 Dec; 110(12):1960. PubMed ID: 21111102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.